Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $421.44 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $212.44 | 6 | $0 (2023) |
| Glaukos Corporation | $121.36 | 2 | $0 (2023) |
| CooperVision Inc. | $83.37 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $83.37 | 1 | CooperVision Inc. ($83.37) |
| 2023 | $279.22 | 6 | ABBVIE INC. ($183.77) |
| 2022 | $54.58 | 2 | ABBVIE INC. ($28.67) |
| 2018 | $4.27 | 1 | TissueTech, Inc. ($4.27) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $83.37 | General |
| Category: Devices | ||||||
| 11/16/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: EYE CARE | ||||||
| 09/27/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Food and Beverage | Cash or cash equivalent | $95.45 | General |
| Category: Corneal Health | ||||||
| 07/14/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: EYE CARE | ||||||
| 05/05/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: EYE CARE | ||||||
| 03/21/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $85.75 | General |
| Category: EYE CARE | ||||||
| 03/09/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: EYE CARE | ||||||
| 08/24/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/05/2022 | GLAUKOS CORPORATION | IACCESS (Device), ISTENT INJECT W | Food and Beverage | Cash or cash equivalent | $25.91 | General |
| Category: OPHTHALMIC KNIFE | ||||||
| 05/16/2018 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $4.27 | General |
| Category: Medical Device (510K) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 265 | 270 | $53,951 | $16,970 |
| 2022 | 6 | 449 | 472 | $101,784 | $33,669 |
| 2021 | 8 | 710 | 748 | $159,244 | $52,222 |
| 2020 | 7 | 648 | 690 | $150,956 | $49,725 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 160 | 160 | $35,122 | $11,357 | 32.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 32 | 32 | $8,382 | $2,673 | 31.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 33 | 38 | $6,280 | $1,651 | 26.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 15 | 15 | $1,984 | $559.32 | 28.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,117 | $498.72 | 44.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 13 | 13 | $1,066 | $231.34 | 21.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 244 | 245 | $62,230 | $20,403 | 32.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 86 | 106 | $17,808 | $6,574 | 36.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 50 | 50 | $15,250 | $4,670 | 30.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 26 | 27 | $3,780 | $1,190 | 31.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 19 | 19 | $1,691 | $458.22 | 27.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 24 | 25 | $1,025 | $373.87 | 36.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 308 | 309 | $78,486 | $24,787 | 31.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 151 | 188 | $31,584 | $11,858 | 37.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 114 | 114 | $34,770 | $11,056 | 31.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 42 | 42 | $5,880 | $1,756 | 29.9% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 19 | 19 | $3,344 | $1,100 | 32.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 32 | 32 | $2,848 | $827.92 | 29.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 33 | 33 | $1,353 | $486.54 | 36.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 11 | 11 | $979.00 | $351.41 | 35.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 293 | 293 | $74,422 | $24,795 | 33.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 116 | 116 | $35,380 | $10,999 | 31.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 143 | 185 | $31,080 | $10,780 | 34.7% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 30 | 30 | $4,200 | $1,303 | 31.0% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2020 | 16 | 16 | $2,816 | $837.33 | 29.7% |
About Bryan Pauls
Bryan Pauls is a Optometrist healthcare provider based in Burlington, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1700166766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bryan Pauls has received a total of $421.44 in payments from pharmaceutical and medical device companies, with $83.37 received in 2024. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($421.44).
As a Medicare-enrolled provider, Pauls has provided services to 2,072 Medicare beneficiaries, totaling 2,180 services with total Medicare billing of $152,585. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Burlington, KS
- Active Since 08/23/2011
- Last Updated 09/21/2023
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1700166766
Products in Payments
- DURYSTA (Drug) $183.77
- KXL system (not refurbished) (Device) $95.45
- MyDay Contact Lens (Device) $83.37
- VUITY (Drug) $28.67
- IACCESS (Device) $25.91
- Prokera (Device) $4.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Burlington
Dr. Robert Levy, O.d, O.D
Optometrist — Payments: $24,423
Samantha Dunnington, Od, OD
Optometrist — Payments: $4,911
Dr. Nazmul Hasan, O.d, O.D
Optometrist — Payments: $4,315
Tod Gerhardt, Od, OD
Optometrist — Payments: $3,785
Jenna Roney, Od, OD
Optometrist — Payments: $3,473
Mr. Richard Shetzline, Od, OD
Optometrist — Payments: $3,393